Positive Results from Phase 3 Trial of Combo Therapy for Multiple Myeloma Presented at ASCO 2016
Researchers from Janssen Research & Development presented promising interim…
Myeloma
Myeloma overview
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreMyeloma treatment
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreLatest news
Study Reveals Multiple Myeloma Treatment Disparities Between Caucasian, African-American Patients
Celgene Corporation recently presented a study comparing overall survival, treatment…
Founder of Multiple Myeloma Research Foundation Named Co-Chair of Harvard’s Kraft Precision Medicine Accelerator
The Multiple Myeloma Research Foundation (MMRF) has announced…
Protein in Multiple Myeloma Patients Linked to Development of Extramedullary Disease
Researchers at the University of Louisville and collaborators from Japan…
Revlimid Maintenance Following Stem Cell Transplant in Multiple Myeloma Patients Appears to Improve Overall Survival
Researchers at Buffalo, New York’s Roswell Park Cancer Institute…
ASCO 2016: Updated Data of MOR202 for Multiple Myeloma Presented by MorphoSys
In a poster presentation at the 2016 ASCO Annual…
